Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 2620-2624, 2023.
Article in Chinese | WPRIM | ID: wpr-997796

ABSTRACT

OBJECTIVE To investigate the occurrence time and risk factors of anemia in patients with acquired immune deficiency syndrome (AIDS) after taking highly active antiretroviral therapy (HAART) containing zidovudine. METHODS The clinical data of 2 150 AIDS patients who were followed up in the care clinic of Liuzhou People’s Hospital from January 1, 2010 to December 31, 2022 were collected. The occurrence time of anemia was analyzed retrospectively, and the risk factors of anemia were analyzed by univariate analysis and binary Logistic regression analysis. RESULTS A total of 854 AIDS patients receiving HAART containing zidovudine were collected, and 107 patients (12.53%) developed anemia. Most of them (63.55%) developed anemia within 3 months after treatment. Baseline hemoglobin [OR=2.944, 95%CI (1.195, 7.501), P=0.019], baseline CD4+ T lymphocyte count [OR=2.472, 95%CI (1.117, 5.469), P=0.026] and baseline human immunodeficiency virus-ribonucleic acid (HIV-RNA) [OR=4.299, 95%CI (1.905, 9.705), P<0.001] was associated with anemia. CONCLUSIONS The median time of anemia in AIDS patients receiving HAART containing zidovudine is the second month after initiation of treatment. Baseline hemoglobin≤110 g/L, baseline CD4+ T lymphocyte E-mail:1315775863@qq.com count≤100 /mm3, and baseline HIV-RNA≥100 000 copies/mL are independent risk factors for anemia in these patients.

2.
Journal of China Pharmaceutical University ; (6): 291-294, 2018.
Article in Chinese | WPRIM | ID: wpr-704337

ABSTRACT

The aim of the work is to improve the synthetic process of dexrabeprazole sodium,enhance quality and yield of the product,simplify synthetic steps,and offer a stable and feasible process. Starting from 2-[[[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methyl]thio]-1 H-benzimidazole,dexrabeprazole was produced by asym-metric oxidation reaction with oxidant cumene hydroperoxide in the presence of chiral catalyst tetraisopropyl titan-ate and L-(+)-tartaric acid diethyl ester. Dexrabeprazole sodium was obtained by the reaction of purified dexrabeprazole with sodium hydroxide in a total yield of 79%with an HPLC purity of >99. 5%. The structure of dexrabeprazole sodium was confirmed by NMR,IR,elemental analysis and LC-MS. The improved process of dexrabeprazole sodium possesses simple operations,good yield and high purity,which is feasible for industrializa-tion.

3.
Journal of Integrative Medicine ; (12): 46-8, 2010.
Article in Chinese | WPRIM | ID: wpr-448935

ABSTRACT

To study the characteristics of eye signs in chronic hepatitis B patients with blood stasis syndrome and the association between blood stasis syndrome and eye signs.

4.
Chinese Journal of Primary Medicine and Pharmacy ; (12)2006.
Article in Chinese | WPRIM | ID: wpr-557978

ABSTRACT

Objective To summarize the clinical characteristic and therapeutic efficacy of lacunar infarction after craniocerebral trauma.Methods 37 cases of children with lacunar infarction after craniocerebral trauma from December 2000 to December 2004 were retrospectively analyzed.Results All of the 37 sufferers received the expectant treatment in hospital.Among the 37 cases,30(81.1%) were well-healed and 7(18.9%) were light maimed when leaving hospital.The clinical symptom of the 29 sufferers completely faded and 7 patients who were light maimed recoverd during the follow-up visit for 6 to 12 months.Conclusions Lacunar infarction after craniocerebral trauma is the syndrome of the damage of the nervous system.Its' major manifestation is the disorder of half body movement.Children with light craniocerebral trauma get this kind of disesase easily.CT scanning and regular re-X can predominantly raise the of the final diagnosis.Most of the sufferers can receive good long-term therapeutic efficacy.

SELECTION OF CITATIONS
SEARCH DETAIL